210 related articles for article (PubMed ID: 9621169)
1. [The cardioprotective action of preparations of biotechnological cytochrome c in acute myocardial ischemia].
Gatsura VV; Sernov LN; Davidov ER
Eksp Klin Farmakol; 1998; 61(2):27-9. PubMed ID: 9621169
[TBL] [Abstract][Full Text] [Related]
2. [The effect of fructose-1,6-diphosphate, cytochrome c and their combination on the size of the necrotic area in transient myocardial ischemia].
Imatdieva RM; Gatsura VV
Eksp Klin Farmakol; 1997; 60(1):32-4. PubMed ID: 9162279
[TBL] [Abstract][Full Text] [Related]
3. [The effect of cytochrome c preparations on the autoregulation of the cerebral blood flow in ischemia].
Pogorelyĭ VE; Gaevyĭ MD; Arl't AV; Davidov ER; Gatsura VV
Eksp Klin Farmakol; 1996; 59(5):18-20. PubMed ID: 9026201
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the vascular wall and ischemic damages to the myocardium in reversible episodes of heart muscle ischemia].
Pozin VM; Skuratovskaia SG; Pocheptsova GA
Fiziol Zh (1994); 1996; 42(1-2):10-6. PubMed ID: 8991704
[TBL] [Abstract][Full Text] [Related]
5. [The protective effect of 17 beta-estradiol in experimental myocardial infarct].
Mambetova AZh; Matiushin AI; Shimanovskiĭ NL; Karachentsev AN
Eksp Klin Farmakol; 1996; 59(2):15-6. PubMed ID: 8974555
[TBL] [Abstract][Full Text] [Related]
6. [The effect of a new phenylalkyl taurine derivative on the size of the necrotic area in experimental myocardial infarct in rats].
Sapronov NS; Torkunov PA; Eliseev VV; Krylova IB; Evdokimova NR
Patol Fiziol Eksp Ter; 1999; (4):19-20. PubMed ID: 10598458
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
8. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents].
Sernov LN; Rozonov IuB; Gatsura VV
Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176
[TBL] [Abstract][Full Text] [Related]
9. [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct].
Goldshteĭne GKh; Tsorin IB; Chichkanov GG
Biull Eksp Biol Med; 1986 Feb; 101(2):177-9. PubMed ID: 3947734
[TBL] [Abstract][Full Text] [Related]
10. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
Syroïd DV; Sokrut VM; Shvyrenko IR
Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078
[TBL] [Abstract][Full Text] [Related]
11. [The effect of phosphoenolpyruvate on the course of the acute period in experimental myocardial infarct].
Sernov LN; Gatsura VV
Biull Eksp Biol Med; 1991 Nov; 112(11):461-2. PubMed ID: 1810475
[TBL] [Abstract][Full Text] [Related]
12. [The effect of the surface-active substance proxanol on the ischemic myocardium].
Ladilov IuV; Islamov BI; Vorob'ev SI
Eksp Klin Farmakol; 1992; 55(2):23-5. PubMed ID: 1422446
[TBL] [Abstract][Full Text] [Related]
13. [The effect of Krebs cycle intermediates on the size of the necrotic zone and on the course of early postocclusion arrhythmia in experimental myocardial infarct in rats].
Sernov LN; Snegireva GV; Gatsura VV
Farmakol Toksikol; 1989; 52(6):47-9. PubMed ID: 2625147
[TBL] [Abstract][Full Text] [Related]
14. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
Makolkin VI; Vakhliaev VD
Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
[TBL] [Abstract][Full Text] [Related]
15. [Transient ischemia as a factor in modelling regulated coronarogenic alteration in the myocardium].
Gatsura VV; Imatdieva RM
Eksp Klin Farmakol; 1994; 57(6):63-5. PubMed ID: 7756970
[TBL] [Abstract][Full Text] [Related]
16. [The cardiotoxic properties of kordaron in acute myocardial ischemia and infarct].
Spasov AA; Gurova NA; Panchenko TI
Eksp Klin Farmakol; 1998; 61(6):25-30. PubMed ID: 9929812
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
Hobbs A; Foster P; Prescott C; Scotland R; Ahluwalia A
Circulation; 2004 Sep; 110(10):1231-5. PubMed ID: 15337698
[TBL] [Abstract][Full Text] [Related]
18. [Effect of nonachlazine on the size of an experimental myocardial infarct].
Gatsura SV; Cherpachenko NM; Turilova AI; Afonskaia NI; Pozonov IuB
Biull Eksp Biol Med; 1984 May; 97(5):574-6. PubMed ID: 6722335
[TBL] [Abstract][Full Text] [Related]
19. [The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
Sernov LN; Rozonov IuB; Sokolova OA; Shal'neva TV; Snegireva GV; Gatsura VV
Biull Eksp Biol Med; 1991 Feb; 111(2):172-3. PubMed ID: 1854962
[TBL] [Abstract][Full Text] [Related]
20. [The anti-ischemic properties of new specific bradycardic agents, derivatives of 2-mercaptobenzimidazole].
Chichkanov GG; Tsorin IB; Kirsanova GIu
Eksp Klin Farmakol; 1998; 61(6):20-4. PubMed ID: 9929811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
